This study evaluated how different exercise and rest schedules during calf-raise exercise affected the stiffness of the calf muscle in trained volleyball athletes. It also examined how muscle stiffness changed during a five-minute recovery period in which percussive therapy was applied.
Thirty volleyball athletes, including 15 women and 15 men, completed three exercise sessions in a randomized order. During each session, participants performed repeated calf raises for a total period of five minutes using one of three work-to-rest schedules: 30 seconds of exercise followed by 30 seconds of rest, 15 seconds of exercise followed by 45 seconds of rest, or 45 seconds of exercise followed by 15 seconds of rest.
The stiffness of the medial gastrocnemius, one of the main calf muscles, was measured using shear-wave elastography. Measurements were taken before exercise, immediately after exercise, and after the five-minute percussive therapy recovery period.
Who can participate
Age range
18 Years – 30 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male or female volleyball athlete aged 18 to 30 years.
* Competing at university or club level.
* At least 3 years of structured volleyball training experience.
* Participating in volleyball training at least 3 times per week.
* Body mass index between 18.5 and 27.0 kg/m².
* No lower-limb musculoskeletal injury during the previous 6 months.
* No known neuromuscular or systemic disorder.
* No use of anti-inflammatory, analgesic, or muscle-relaxant medication during the week before testing.
Exclusion Criteria:
* Failure to attend or complete any of the three experimental sessions.
* Performance of vigorous exercise within 24 hours before a testing session.
* Occurrence of an adverse event that prevented adherence to or completion of the study protocol.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Mean Change in Medial Gastrocnemius Shear-Wave Velocity
Timeframe: Baseline, immediately after each 5-minute calf-raise protocol, and after the subsequent 5-minute percussive therapy recovery period, during each of 3 sessions separated by at least 48 hours.
Trial details
NCT IDNCT07745452
SponsorPrincess Nourah Bint Abdulrahman University